The compound 33i, a new SIRT2 inhibitor, as a potential treatment for Alzheimer’s disease

Alzheimer s disease (AD) is the most common form of dementia and one of the leading causes of morbidity and mortality in the aging population. Although its exact etiology remains to be elucidated, it is likely to result from complex interactions between genetic, epigenetic, and environmental factors...

Full description

Bibliographic Details
Main Authors: Díaz-Perdigón, T. (Teresa), Puerta, E. (Elena), Tordera, R.M. (Rosa María)
Format: info:eu-repo/semantics/doctoralThesis
Language:eng
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/10171/58000